Mentice AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0012673291
SEK
14.65
-0.8 (-5.18%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Mentice AB stock-summary
stock-summary
Mentice AB
Pharmaceuticals & Biotechnology
Mentice AB is a Sweden-based medical technology company. It provides software and hardware simulation solutions and related services for endovascular therapies. The Company’s solutions help healthcare professionals acquire, retain, and enhance their procedural skills. The Company’s solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. The Company also covers neurovascular, cardiovascular and peripheral interventions, among others. It is active globally.
Company Coordinates stock-summary
Company Details
Odinsgatan 10 , GOETEBORG NE : 411 03
stock-summary
Tel: 46 31 339940046 703 092222
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Lawrence Howell
Chairman of the Board
Mr. David Ballard
Director
Mr. Magnus Hardmeier
Director
Mr. Gosta Johannesson
Director
Mr. Denis Gestin
Independent Director
Mr. Johann Koss
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
63 Million
(Quarterly Results - Jun 2025)
Net Profit:
-18 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 385 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.26

stock-summary
Return on Equity

-34.37%

stock-summary
Price to Book

3.06